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See related research by Kaynar et al., http://ccforum.com/content/18/5/469Cardiovascular events have been associated with previous
infections in many observational studies. In the previous
issue of Critical Care, Kaynar and colleagues [1] corrobo-
rated this association by showing in atherosclerosis-prone
mice that the cecal-ligation-and-puncture (CLP) model of
sepsis accelerates aortic atherosclerotic plaque formation
up to 5 months after CLP. In addition, the authors ob-
served higher circulating interleukin-6 and -10 levels and
a greater infiltration of macrophages in the aortic root at
5 months after CLP. Although these findings substantiate
the association between infection and atherosclerosis, the
underlying mechanism of the persistent inflammation
remains enigmatic.
We propose the newly described process of trained im-
munity as the mechanistic link between previous infection
and atherosclerosis. Trained immunity denotes the non-
specific immunological memory that can be activated in
monocytes [2,3]. Brief exposure of monocytes to microbial
products (including Candida albicans or its cell wall* Correspondence: niels.riksen@radboudumc.nl
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unless otherwise stated.component beta-glucan) induces a long-lasting pro-
inflammatory macrophage phenotype via epigenetic re-
programming mediated by histone modifications [2,3].
Further analyses revealed global pan-activation of these
macrophages rather than simple skewing into M1 or M2
subtypes [3].
Given the pivotal role for monocytes/macrophages in
atherosclerotic plaque development, we recently hypo-
thesized that trained innate immunity contributes to
atherosclerosis [4]. Indeed, epigenetic reprogramming of
monocytes induced a long-lasting pro-atherosclerotic
phenotype, characterized by increased cytokine and che-
mokine release and increased foam cell formation [5].
Considering these findings, we propose that epigenetic
reprogramming of monocytes after CLP explains the per-
sistent inflammation and accelerated atherosclerosis. Since
epigenetic reprogramming is amenable to pharmacological
modulation, further elucidation of this mechanism might
provide novel treatment strategies for atherosclerosis [5].sWe read the letter by Bekkering and colleagues with inter-
est. We completely agree that the mechanism behind the
sustained inflammation 5 months after recovery from sep-
sis remains enigmatic. The goal of our article [1] was to
overcome the shortcomings of prior human observational
studies by constructing an experiment model in which we
could make causal inference. However, although we have
helped establish a causal relationship, we do not know
‘how’ it actually happens. We concur that there could be
innate ‘training’ through epigenetic changes leading toaugmented inflammatory response by monocytes/macro-
phages in the absence of ongoing infection. As re-
ported by the group, the concept of ‘learned innate
immunity’ brings the innate immunity to the limelight
[2]. However, the decision tree when the innate immunity
does switch from a ‘tolerant’ to an energetically costly
‘learned’ state is not clear [1,6,7].
To conclude, we also think that ‘learned immunity’
could play a role in our observations. However, is ‘learned
immunity’ really of benefit to the organism? If not, why do
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